A Roche Holding AG study of its experimental breast-cancer drug in combination with another treatment failed to meet the ...

During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky.

The results of the clinical trial mark a setback for the Swiss pharmaceutical company, which saw in the drug, giredestrant, a candidate to become a blockbuster treatment.

Exhaustion creeps in. Appetite vanishes. Hair thins. The person in the mirror looks gaunt. It's the paradox of cancer treatment: The same drugs meant to save a life can also wear the body down. Nick ...

With few treatments available to stop or reverse Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline. Alzheimer’s cases are rising in the ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

It may be best not to go off-script when it comes to breast cancer. Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women ...

In recent years, scientists have discovered that some chemotherapy drugs not only kill cancer cells directly, but at least in some patients, mysteriously also trigger their immune system to attack the ...

Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Surgeon Gareth Honeybone wants wider access to zanidatamab to treat one of the deadliest cancers.